Michael Felo, Director, Downstream Process Integration, Next Generation Processing, MilliporeSigma shares his insight with Contract Pharma at Interphex 2019
The "Meeting Bioprocessing Manufacturing Capacity Demands” panel session at Interphex 2019 focused on solutions for efficient and cost-effective biologic drug manufacturing.
The panelists included:
Michael Felo, Director, Downstream Process Integration, Next Generation Processing, MilliporeSigma
Eric S Langer, President and Managing Partner, BioPlan Associates, Inc.
Rick Morris, Senior Vice President R&D, Pall Biotech, Pall Corporation
Steve Perry, Senior Director, Manufacturing Sciences, Catalent Biologics
Brady Cole, Vice President, Applications, ABEC
Madhu Raghunathan, Product Strategy Leader – BioProcess Hardware, GE Healthcare Life Sciences
The discussion took place on April 3, 11:00 a.m. – noon, innovation stage, #1281. One of the participants, Michael Felo of Millipore Sigma
, spoke with Contract Pharma to share the company's thoughts on the subject, along with his strategy and expertise.